Link - The Synthetic Ep 4 Beta By Carbon

For the medicinal chemist or cell biologist frustrated by the instability of natural prostanoids, offers a solution. It combines the high-affinity activation of the EP4 receptor with the rugged stability of a synthetic hydrocarbon backbone.

| Feature | Native PGE2 | The Synthetic EP4 Beta by Carbon Link | | :--- | :--- | :--- | | | Oxygen ester | Carbon-carbon (alkyl) link | | Half-life in buffer | ~2 hours (rapid) | >72 hours (highly stable) | | Selectivity | Non-selective (EP1,2,3,4) | High affinity EP4 (little/no EP2/EP1) | | Solubility | Moderate (oil based) | Enhanced due to modified logP | | Best for | Acute, broad profiling | Chronic, selective pathway mapping | the synthetic ep 4 beta by carbon link

Whether you are investigating bone loss, cancer immunity, or intestinal homeostasis, switching to this carbon-linked analogue ensures that your results reflect the biology of EP4—not the chemistry of degradation. For the medicinal chemist or cell biologist frustrated

EP4 has dual roles in colitis. Acute activation protects the mucosal barrier, but chronic activation promotes fibrosis. The selective, context-dependent action of the synthetic beta analog allows for tailored therapy. Animal studies show reduced disease activity index and preserved epithelial integrity. EP4 has dual roles in colitis

Synthetic EP4β by Carbon Link is not yet a marketed drug but is a powerful . Current and potential applications include:

If this is an internal or niche project, you can use the following structure to draft your report.